We are live on ! Find out more
AKRO

Akero Therapeutics
AKRO

Delisted

AKRO was delisted on the 8th of December, 2025.

Back to rankings

257 hedge funds and large institutions have $4.92B invested in Akero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 87 increasing their positions, 87 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $100M | Put options by funds: $48.2M

46% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 39

40% more capital invested

Capital invested by funds: $3.5B → $4.92B (+$1.41B)

23% more funds holding in top 10

Funds holding in top 10: 13 → 16 (+3)

7% more funds holding

Funds holding: 240 → 257 (+17)

7.02% more ownership

Funds ownership: 108.56% → 115.58% (+7%)

0% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 87

Holders
257
Holders Change
+17
Holders Change %
+7.08%
% of All Funds
3.38%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.21%
New
57
Increased
87
Reduced
87
Closed
39
Calls
$100M
Puts
$48.2M
Net Calls
+$51.8M
Net Calls Change
+$37.2M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$159M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$100M
3
WP
Woodline Partners
California
+$90.3M
4
Holocene Advisors
Holocene Advisors
New York
+$48.9M
5
Bank of America
Bank of America
North Carolina
+$48.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$115M
2
RI
RTW Investments
New York
-$88.2M
3
SG Americas Securities
SG Americas Securities
New York
-$52.3M
4
Citadel Advisors
Citadel Advisors
Florida
-$33.6M
5
BlackRock
BlackRock
New York
-$21.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CMBA
251
C.M. Bidwell & Associates
Hawaii
$534 – – –
BFS
252
Bare Financial Services
Pennsylvania
$534 +$454 +10 New
EP
253
Essential Partners
California
$267 +$227 +5 New
TPWA
254
Twin Peaks Wealth Advisors
California
$192 +$182 +4 New
SS
255
SBI Securities
Japan
$107 – – –
TFM
256
TFC Financial Management
Massachusetts
$107 – – –
Lord, Abbett & Co
257
Lord, Abbett & Co
New Jersey
– -$21.3M -527,004 Closed
Voloridge Investment Management
258
Voloridge Investment Management
Florida
– -$20.3M -501,485 Closed
RCW
259
Rheos Capital Works
Japan
– -$11.2M -276,000 Closed
Jane Street
260
Jane Street
New York
– -$8.29M -182,457 Closed
CSS
261
Cubist Systematic Strategies
Connecticut
– -$7.08M -174,960 Closed
Qube Research & Technologies (QRT)
262
Qube Research & Technologies (QRT)
United Kingdom
– -$6.08M -150,142 Closed
ECM
263
ExodusPoint Capital Management
New York
– -$4.21M -103,930 Closed
SCM
264
Sio Capital Management
New York
– -$3.44M -85,000 Closed
EAM
265
Exome Asset Management
New York
– -$3.47M -76,379 Closed
EI
266
EAM Investors
California
– -$2.69M -66,422 Closed
Two Sigma Investments
267
Two Sigma Investments
New York
– -$2.51M -62,020 Closed
Man Group
268
Man Group
United Kingdom
– -$1.85M -45,709 Closed
Simplex Trading
269
Simplex Trading
Illinois
– -$1.86M -40,853 Closed
DFCM
270
Dark Forest Capital Management
Puerto Rico
– -$1.55M -38,190 Closed
CF
271
Corebridge Financial
Texas
– -$1.48M -36,523 Closed
AIM
272
Aigen Investment Management
New York
– -$820K -20,253 Closed
SFAM
273
Springhill Fund Asset Management
Hong Kong
– -$807K -19,925 Closed
UOC
274
UBS O'Connor
Illinois
– -$761K -18,800 Closed
Verition Fund Management
275
Verition Fund Management
Connecticut
– -$746K -18,417 Closed
8 9 10
11
12

AKRO Hedge Fund Activity: Q2 2025 in Review

257 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Akero Therapeutics (AKRO) for Q2 2025, worth a combined $4.92B — up 40% from $3.5B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AKRO positions and 39 closed out — a net gain of 18 holders — while 87 added to existing stakes and 87 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $159M. The largest seller was Wellington Management Group, cutting an estimated $115M.

  • 257 institutional investors held Akero Therapeutics (AKRO) as of Q2 2025, up from 240 in Q1 2025.
  • Funds reported $4.92B of Akero Therapeutics stock for Q2 2025, up 40% quarter-over-quarter.
  • 57 funds opened new Akero Therapeutics positions in Q2 2025 and 39 closed out, a net change of +18 holders.
  • The largest Akero Therapeutics buyer in Q2 2025 was Avoro Capital Advisors, an estimated $159M added.
  • The largest Akero Therapeutics seller in Q2 2025 was Wellington Management Group, an estimated $115M sold.

Based on aggregated 13F filings for Q2 2025.